To demonstrate that, we analyzed IL-33 expression in normal human epidermal keratinocytes (NHEKs) treated with IL-4, an important Th2 cytokine; such treatment can be used to establish an in vitro AD model [11]. The gene discussed is IL4; the disease is Alzheimer disease.